Abstract-Head-twitches have been regarded as an experimental model of hal lucination, and we have recently observed that p-hydroxyamphetamine (p-OHA) markedly induced head-twitches in mice. The present work was undertaken to study possible participation of a serotonergic system in the mechanism of head twitches induced by p-OHA. Head-twitches induced by p-OHA continued for 20-80 min, and the peak time of this effect was approximately 30-40 ruin after the administration. The i.c.v. administration of p-OHA (20, 40, 80 and 160 itg/mouse) produced characteristic head-twitches in a dose-dependent manner.
Recently, we have observed that of many I -phenylethylamine derivatives tested, only p-hydroxyamphetamine (p-OHA) induced a head-twitches in mice. Head-twitches have been regarded as an experimental model for hallucination, since many drugs that produce hallucination such as LSD (1-3) or mescaline (3) have induced head-twitches in mice, but 49-tetrahydrocannabinol did not (3). Fur thermore, similar head-twitches have been elicited by other treatments including admin istration of atropine (3), 5-hydroxytryp tophan (4-6), 5-hyroxytryptamine (5-HT) (7-10), and quipazine (11, 12) and ethanol withdrawal (13, 14) . Thus, a major metabolite of amphetamine, p-OHA may be concerned with amphetamine-induced schizophrenia. Detailed information concerning the p-OHA induced head-twitches, however, has not been available.
The present study was undertaken to elucidate the role of the brain serotonergic system in the head-twitches induced by p OHA.
Materials and Methods
Groups of ten male ddY strain mice (20 24 g) were used. They were allowed free access to food and water except during the experiment.
The animals were housed in room with a 12-hr light-dark cycle and relatively constant environment (22±2'C and 55±5% humidity). All behavioral studies were performed between 10:00 a.m. and 6:00 p.m.
The number of head-twitches was counted for 2 min with 10 min intervals between 10 and 92 min after the intracerebroventricular (i.c.v.) administration of p-OHA. The total number of head-twitches was measured for 90 min after the i. increased the spontaneous motor activity and the number of head-twitches accompanied by piloerection, salivation and weeping in mice. Head-twitches induced by p-OHA continued for 20-80 min, and the peak time of head-twitches was approxi mately 30 min after the i.c.v. administration of p-OHA. The total number of head-twitches for 90 min was 3 at a dose of 20 ,ug/mouse, 7 at 40 ig/mouse, 13 at 80 /cg/mouse and 29 at 160 ,ag/mouse. Thus, the i.c.v. adminis tration of p-OHA showed a dose dependent rise in the number of head-twitches (Fig. 1) . Effects of serotonergic drugs on the head twitches: The i.c.v. administration of 5-HT alone caused head-twitches in naive mice, and it's intensity and duration were more marked than in mice treated with Ringer. A dose of 5-HT (10 ,ug/mouse, i.c.v.) which did not elicite head-twitches, was used to see the combined effect of 5-HT and p-OHA. Simultaneous injection of 5-HT and p-OHA increased 2.2-2.6-fold the total number of head-twitches compared with non-serotonin control groups (Fig. 2) . Pretreatment with p-chlorophenylalanine (p-CPA), a serotonin biosynthesis inhibitor, dose-dependently reduced head-twitches induced by p-OHA. p-CPA (200 mg/kg, i.p.) reduced head twitches induced by p-OHA, with a maximum reduction at 30 min and a gradual decline from 70-90 min after injection. The total number of p-OHA-induced head-twitches was completely blocked by three consecutive injections of p-CPA (Fig. 3) . The total number of head-twitches for 90 min in mice pretreated with p-CPA methylester (500 pg/ mouse x1, 2 and 3 days, i.c.v.) was ap proximately 1 /4-1 /3 of that in mice not treated with p-CPA methylester (data not shown).
Several other drugs that block serotonergic receptors in the brain were also tested for their ability to change the intensity of head-twitches evoked by p-OHA. Cyproheptadine reduced the total number of p-OHA-induced head-twitches in a dose dependent-manner. Dimethothiazine also showed a dose related decrease in the total number of p-OHA-induced head-twitches (Table 1) .
Discussion
It has been widely accepted that amphe tamine elicits abnormal behavior (16) (17) (18) and changes regional brain catecholamine levels (19, 20) . The abnormal behavior induced by amphetamine has been reported to be related to a direct antagonist action at catecholamine receptors (21, 22) , a catechol amine-releasing action, an inhibition of re uptake released catecholamine (23, 24) and a MAO inhibition (25). After the adminis tration of amphetamine, it's metabolite, p OHA is highly accumulated in the hypo thalamus and striatum (26). Furthermore, Randrup and Munkvate (27) have reported that p-OHA in doses of 50-200 /cg/rat, injected bilaterally into the rat caudate induced by p-OHA may be due to the metabolism of amphetamine.
In the present study, the i.c.v. adminis tration of p-OHA, one of the metabolites of amphetamine and methamphetamine, induced head-twitch which has been proposed as an experimental model for hallucination (1-3), since hallucinogens strongly induce this response in mice (1-3). Therefore, it is assumed that p-OHA-induced head-twitches may be a symptom of hallucination. As well as a wide range of hallucinogens, 5-HTP (4-6), 5-HT (7-10) and tyramine (5, 9, 10) also induce head-twitches in mice. Head twitches evoked by these drugs may involve the serotonergic system in the brain, since effects caused by these drugs are preferen tially blocked by antiserotonergic drugs such as dimethothiazine and cyproheptadine, and they are markedly enhanced by i.c.v. injection of 5-HT (9). In this study, p-CPA, a 5-HT 
